# Lacosamide

## Vimpat Intravenous 200mg/20mL

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IVIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 適應症     | Monotherapy for patients with localized seizures over the age of 4. Assistance to (1) complex partial seizure and (2) simple or complex partial seizure with secondary generalization over 4 years of age Add-on therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 用法用量   | Adults (17 years and older): Monotherapy: Initial Dosage: 100 mg twice daily (200 mg per day) Titration Regimen: Increase by 50 mg twice daily (100 mg per day) every week. Maintenance Dosage: 150 mg to 200 mg twice daily (300 mg to 400 mg per day). Adults (17 years and older): Adjunctive Therapy: Initial Dosage: 50 mg twice daily (100 mg per day) Titration Regimen: Increase by 50 mg twice daily (100 mg per day) every week. Maintenance Dosage: 100 mg to 200 mg twice daily (200 mg to 400 mg per day). Adults (17 years and older): Alternate Initial Dosage: 200 mg single loading dose, followed 12 hours later by 100 mg twice daily. Pediatric patients weighing 50 kg or more: Initial Dosage: 50 mg twice daily (100 mg per day). Titration Regimen: Increase by 50 mg twice daily (100 mg per day) every week. Maintenance Dosage: Monotherapy: 150 mg to 200 mg twice daily (300 mg to 400 mg per day). Adjunctive Therapy: 100 mg to 200 mg twice daily (200 mg to 400 mg per day). Maximum recommended dose: 400 mg per day. |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 禁忌       | Allergic to the main ingredients or any excipients. second-or third-degree AV block.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 副作用     | Common Gastrointestinal: Nausea (up to 24% ) Neurologic: Dizziness (Oral, 16% to 30% ; IV, 20% to 60% ), Headache (11% to 16% ) Ophthalmic: Diplopia (9% to 11% ) Serious Cardiovascular: Atrial fibrillation and flutter, First degree atrioventricular block, Asymptomatic (0.4% ), Prolonged PR interval Immunologic: Drug reaction with eosinophilia and systemic symptoms Psychiatric: Suicidal behavior, Suicidal thoughts                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 孕期建議   | No (limited) human data – animal data suggest moderate risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## Vimpat 100mg

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OVIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 適應症     | Monotherapy for patients with localized seizures over the age of sixteen. Assistance to (1) complex partial seizure and (2) simple or complex partial seizure with secondary generalization over 4 years of age Add-on therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 用法用量   | Adults (17 years and older): Monotherapy: Initial Dosage: 100 mg twice daily (200 mg per day) Titration Regimen: Increase by 50 mg twice daily (100 mg per day) every week. Maintenance Dosage: 150 mg to 200 mg twice daily (300 mg to 400 mg per day). Adults (17 years and older): Adjunctive Therapy: Initial Dosage: 50 mg twice daily (100 mg per day) Titration Regimen: Increase by 50 mg twice daily (100 mg per day) every week. Maintenance Dosage: 100 mg to 200 mg twice daily (200 mg to 400 mg per day). Adults (17 years and older): Alternate Initial Dosage: 200 mg single loading dose, followed 12 hours later by 100 mg twice daily. Maximum recommended dose: 400 mg per day. |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 禁忌       | Allergic to the main ingredients or any excipients. second-or third-degree AV block.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 副作用     | Common Gastrointestinal: Nausea (up to 24% ) Neurologic: Dizziness (Oral, 16% to 30% ; IV, 20% to 60% ), Headache (11% to 16% ) Ophthalmic: Diplopia (9% to 11% ) Serious Cardiovascular: Atrial fibrillation and flutter, First degree atrioventricular block, Asymptomatic (0.4% ), Prolonged PR interval Immunologic: Drug reaction with eosinophilia and systemic symptoms Psychiatric: Suicidal behavior, Suicidal thoughts                                                                                                                                                                                                                                                                    |
| 孕期建議   | No (limited) human data – animal data suggest moderate risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

